You just read:

Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013

News provided by

Genocea Biosciences Inc.

Sep 12, 2013, 05:00 ET